Kuros Biosciences AG - Asset Resilience Ratio

Latest as of June 2025: 16.77%

Kuros Biosciences AG (KURN) has an Asset Resilience Ratio of 16.77% as of June 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Check strategic asset allocation of Kuros Biosciences AG to assess the company's strategic physical and investment asset allocation.

Liquid Assets

CHF18.44 Million

≈ $23.32 Million USD Cash + Short-term Investments

Total Assets

CHF109.97 Million

≈ $139.03 Million USD All company assets

Resilience Assessment

Good

Financial Resilience Level

Asset Resilience Ratio Trend (2005–2023)

This chart shows how Kuros Biosciences AG's Asset Resilience Ratio has changed over time. See Kuros Biosciences AG (KURN) net asset quality to measure how much of total assets are equity-financed.

Liquid Assets Composition Over Time

This chart breaks down Kuros Biosciences AG's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see Kuros Biosciences AG market capitalisation.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	CHF18.44 Million	16.77%
Short-term Investments	CHF0.00	0%
Total Liquid Assets	CHF18.44 Million	16.77%

Asset Resilience Insights

Good Liquidity Position: Kuros Biosciences AG maintains a healthy 16.77% of assets in liquid form.
This level provides good financial flexibility while maintaining productive asset deployment.
The company primarily holds liquidity in cash and equivalents rather than short-term investments.

Kuros Biosciences AG Industry Peers by Asset Resilience Ratio

Compare Kuros Biosciences AG's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Jiangsu Yuyue Medical Equipment & Supply Co Ltd SHE:002223	Medical Devices	0.84%
Novocure Ltd NASDAQ:NVCR	Medical Devices	43.72%
Shanghai MicroPort EV MedTech Co. Ltd. A SHG:688351	Medical Devices	49.23%
Jafron Biomedical Co Ltd SHE:300529	Medical Devices	39.15%
Anteris Technologies Global Corp AU:AVR	Medical Devices	33.27%
Beijing Chunlizhengda Medical Instruments Co Ltd SHG:688236	Medical Devices	25.01%
Tellgen Corp SHE:300642	Medical Devices	9.96%
EBR Systems Inc AU:EBR	Medical Devices	54.70%

Annual Asset Resilience Ratio for Kuros Biosciences AG (2005–2023)

The table below shows the annual Asset Resilience Ratio data for Kuros Biosciences AG.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2023-12-31	0.48%	CHF342.00K ≈ $432.38K	CHF71.46 Million ≈ $90.35 Million	-1.52pp
2015-12-31	1.99%	CHF65.00K ≈ $82.18K	CHF3.26 Million ≈ $4.12 Million	-10.99pp
2011-12-31	12.98%	CHF4.00 Million ≈ $5.06 Million	CHF30.81 Million ≈ $38.96 Million	-1.81pp
2010-12-31	14.80%	CHF8.00 Million ≈ $10.11 Million	CHF54.07 Million ≈ $68.36 Million	-39.06pp
2009-12-31	53.86%	CHF37.00 Million ≈ $46.78 Million	CHF68.70 Million ≈ $86.86 Million	+16.84pp
2008-12-31	37.02%	CHF41.00 Million ≈ $51.84 Million	CHF110.75 Million ≈ $140.02 Million	-16.40pp
2007-12-31	53.42%	CHF66.00 Million ≈ $83.44 Million	CHF123.56 Million ≈ $156.21 Million	+22.06pp
2006-12-31	31.35%	CHF18.00 Million ≈ $22.76 Million	CHF57.41 Million ≈ $72.58 Million	+30.89pp
2005-12-31	0.46%	CHF379.00K ≈ $479.16K	CHF82.39 Million ≈ $104.17 Million	--

pp = percentage points

About Kuros Biosciences AG

SW:KURN Switzerland Medical Devices

Market Cap

$1.00 Billion

CHF792.91 Million CHF

Market Cap Rank

#10354 Global

#126 in Switzerland

Share Price

CHF20.20

Change (1 day)

-1.94%

52-Week Range

CHF18.82 - CHF33.36

All Time High

CHF36.96